コンテンツへスキップ
Merck

SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.

Journal of cell science (2014-12-05)
Katrin Diesenberg, Monika Beerbaum, Uwe Fink, Peter Schmieder, Michael Krauss
要旨

Septins constitute a family of GTP-binding proteins that are involved in a variety of biological processes. Several isoforms have been implicated in disease, but the molecular mechanisms underlying pathogenesis are poorly understood. Here, we show that depletion of SEPT9 decreases surface levels of epidermal growth factor receptors (EGFRs) by enhancing receptor degradation. We identify a consensus motif within the SEPT9 N-terminal domain that supports its association with the adaptor protein CIN85 (also known as SH3KBP1). We further show CIN85-SEPT9 to be localized exclusively to the plasma membrane, where SEPT9 is recruited to EGF-engaged receptors in a CIN85-dependent manner. Finally, we demonstrate that SEPT9 negatively regulates EGFR degradation by preventing the association of the ubiquitin ligase Cbl with CIN85, resulting in reduced EGFR ubiquitylation. Taken together, these data provide a mechanistic explanation of how SEPT9, though acting exclusively at the plasma membrane, impairs the sorting of EGFRs into the degradative pathway.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗α-チューブリン マウス宿主抗体, ascites fluid, clone B-5-1-2
Sigma-Aldrich
モノクロナール抗MAPキナーゼ, 活性化 (二リン酸化型ERK-1&2) マウス宿主抗体, clone MAPK-YT, ascites fluid
Sigma-Aldrich
抗6-Sep抗体 ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution